The study examined the effect of serotonin (5-HT) on gonadotrophin release and its tissue site of action using a sequential double chamber perifusion system. Cycling female rats were killed between 12.00 and 13.00 h on the day of proestrus. Median eminences and anterior pituitaries were removed and transferred to perifusion chambers. Two types of experiments were performed: a) five median eminences (ME) were placed in the first chamber and one anterior pituitary in the second chamber. b) In the second group, only the anterior pituitary was perifused. The effluent from the first chamber perifused the second chamber. The effluent from the second chamber was collected for hormone assays. Addition of serotonin (final concentration 0.06, 0.6 and 6.0 uM) stimulated the release of LH and FSH into the perifusion fluid draining the pituitary in series with the median eminences. Pretreatment with the 5-HT receptor blocker cyproheptadine (1 uM) completely inhibited the stimulatory effect of 5-HT. Serotonin was ineffective in stimulating gonadotrophin release when injected into the tube connecting the first and the second chambers (50 ul of 0.6 uM solution) or when the anterior pituitary was perifused alone. Serotonin did not affect the prolactin release in any of the experimental conditions studied. These observations demonstrate that serotonin stimulated the gonadotrophin release by acting on serotoninergic receptors at the level of the median eminence.

Download full-text PDF

Source

Publication Analysis

Top Keywords

gonadotrophin release
16
median eminences
12
anterior pituitary
12
second chamber
12
release acting
8
median eminence
8
pituitary perifused
8
serotonin
6
release
6
chamber
6

Similar Publications

Background: Growth hormone (GH) could improve the outcomes of fertilization and embryo transfer (IVF-ET) in patients with decreased ovarian reserve (DOR), but which age group will benefit the most has remained controversial. This study aims to explore the outcome of IVF-ET among differently aged patients with DOR treated with GH.

Methods: A total of 846 patients with DOR undergoing IVF-ET from May 2018 to June 2023 at the Reproductive Medicine Center of Sichuan Provincial Women's and Children's Hospital were prospectively enrolled.

View Article and Find Full Text PDF

Oral contraceptives (OCs) are approved for use after onset of menarche, which is well before brain maturation is complete. OC use may induce biochemical changes in the brain, especially during the neurobiologically dynamic adolescent/young adult years. MicroRNA cargo in L1CAM-associated extracellular vesicles was measured from serum samples collected from young women using the miRCURY LNA miRNA Focus PCR Panel (Qiagen) and validated using quantitative PCR.

View Article and Find Full Text PDF

Overexpression of the gonadotropin-releasing hormone receptor (GnRH-R) plays a vital role in the advancement of reproductive malignancies such as ovarian, endometrial, and prostate cancer. Peptidomimetic GnRH antagonists are a substantial therapeutic development, providing fast and reversible suppression of gonadotropins by directly blocking GnRH-R. Unlike typical GnRH agonists, these antagonists prevent the early hormonal flare, have a faster onset of action, and have a lower risk of cardiovascular problems.

View Article and Find Full Text PDF

Nutritional intake is closely linked to gonadal development, although the mechanisms by which food intake affects gonadal development are not fully understood. Cholecystokinin (CCK) is a satiety neuropeptide derived from the hypothalamus, and the present study observed that hypothalamic CCK expression is significantly influenced by food intake, which is mediated through blood glucose levels. Interestingly, CCK and its receptors were observed to exhibit a high expression in the hypothalamus-pituitary-gonad (HPG) axis of grass carp (), suggesting that CCK is potentially involved in regulating fish reproduction through the HPG axis.

View Article and Find Full Text PDF

Triggering final follicular maturation for IVF cycles.

Reprod Biol Endocrinol

January 2025

Infertility and IVF Unit, Department of Obstetrics and Gynecology, Chaim Sheba Medical Center (Tel Hashomer), Ramat Gan, 52621, Israel.

As part of a conventional controlled ovarian hyperstimulation (COH) regimen, final follicular maturation is usually triggered by a single bolus dose of human chorionic gonadotropin (hCG). COH, which combines GnRH antagonist co-treatment with GnRH agonist(GnRHa) trigger, is often used in attempts to eliminate severe early ovarian hyperstimulation syndrome and to improve oocyte/embryo yield and quality. Recently, the combination of GnRHa, with hCG trigger has also been implemented into clinical practice.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!